Aclarion Price Target Cut to $1.50/Share From $1.60 by Ascendiant Capital
Aclarion Analyst Ratings
Maxim Group Maintains Aclarion(ACON.US) With Buy Rating
Maxim Group Maintains Aclarion(ACON.US) With Buy Rating
Maxim Group Remains a Buy on Aclarion, Inc. (ACON)
Ascendiant Capital Initiates Coverage On Aclarion With Buy Rating, Announces Price Target of $1.6
Aclarion Analyst Ratings
Ascendiant Initiates Aclarion(ACON.US) With Buy Rating, Announces Target Price $1.6
Analysts Are Bullish on Top Healthcare Stocks: Calliditas Therapeutics (CALT), Aclarion, Inc. (ACON)
Aclarion, Inc. (ACON) Receives a Buy From Maxim Group
No Data
No Data